Butac, Normie .
HRN: 23-08-66 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/04/2023
CEFUROXIME 500MG (TAB)
07/04/2023
07/10/2023
PO
1 Tab
BID
S/p NSVD W/ RMLE
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes